Drugs / MK-5720
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05953740 | Sep 2023 → Feb 2024 | schizophrenia | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MK-5720 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05953740 ↗ |
| Route | Intramuscular | “single intramuscular (IM) injection of MK-5720” NCT05953740 ↗ |